🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/10/1992 | 20,28 | 20,52 | 20,04 | 20,22 | +0,00% | 2,35% | 4.768.819 |
| 06/10/1992 | 20,57 | 20,63 | 19,98 | 20,22 | -1,17% | 3,19% | 6.357.378 |
| 05/10/1992 | 20,28 | 20,52 | 19,32 | 20,46 | -0,29% | 5,88% | 9.872.370 |
| 02/10/1992 | 21,05 | 21,17 | 20,46 | 20,52 | -2,55% | 3,40% | 5.977.582 |
| 01/10/1992 | 21,35 | 21,47 | 20,99 | 21,05 | -0,84% | 2,23% | 5.394.685 |
| 30/09/1992 | 21,23 | 21,35 | 21,05 | 21,23 | +1,14% | 1,40% | 4.579.131 |
| 29/09/1992 | 20,57 | 21,17 | 20,52 | 20,99 | +1,73% | 3,19% | 5.525.475 |
| 28/09/1992 | 20,63 | 20,69 | 20,16 | 20,63 | -1,14% | 2,60% | 7.992.467 |
| 25/09/1992 | 21,47 | 21,53 | 20,16 | 20,87 | -4,11% | 6,39% | 12.468.056 |
| 24/09/1992 | 22,19 | 22,24 | 21,53 | 21,77 | -2,41% | 3,23% | 9.203.117 |
| 23/09/1992 | 22,19 | 22,36 | 22,13 | 22,30 | +0,27% | 1,08% | 3.167.685 |
| 22/09/1992 | 22,24 | 22,42 | 22,07 | 22,24 | +0,27% | 1,61% | 4.257.605 |
| 21/09/1992 | 22,48 | 22,60 | 22,13 | 22,19 | -1,85% | 2,12% | 4.815.350 |
| 18/09/1992 | 22,13 | 22,72 | 21,95 | 22,60 | +0,80% | 3,50% | 8.915.126 |
| 17/09/1992 | 22,54 | 22,66 | 22,30 | 22,42 | +0,00% | 1,59% | 3.299.523 |
| 16/09/1992 | 22,54 | 22,78 | 22,30 | 22,42 | -1,05% | 2,12% | 5.349.621 |
| 15/09/1992 | 23,02 | 23,20 | 22,54 | 22,66 | -2,31% | 2,85% | 4.001.474 |
| 14/09/1992 | 23,20 | 23,26 | 22,60 | 23,20 | +1,30% | 2,83% | 4.391.330 |
| 11/09/1992 | 22,90 | 22,96 | 22,66 | 22,90 | +0,26% | 1,30% | 2.722.914 |
| 10/09/1992 | 23,08 | 23,14 | 22,84 | 22,84 | -0,52% | 1,29% | 3.011.952 |
| 09/09/1992 | 22,96 | 23,08 | 22,84 | 22,96 | -0,26% | 1,04% | 2.861.878 |
| 08/09/1992 | 23,38 | 23,44 | 22,90 | 23,02 | -1,53% | 2,30% | 3.106.691 |
| 04/09/1992 | 23,08 | 23,80 | 22,96 | 23,38 | +1,55% | 3,62% | 2.634.462 |
| 03/09/1992 | 23,08 | 23,50 | 23,02 | 23,02 | +0,52% | 2,07% | 6.106.277 |
| 02/09/1992 | 23,14 | 23,20 | 22,78 | 22,90 | -0,52% | 1,80% | 4.870.266 |
| 01/09/1992 | 23,20 | 23,50 | 22,96 | 23,02 | -0,77% | 2,31% | 4.652.701 |
| 31/08/1992 | 23,38 | 23,38 | 23,08 | 23,20 | -1,52% | 1,28% | 3.888.290 |
| 28/08/1992 | 23,74 | 23,80 | 23,32 | 23,56 | -1,00% | 2,01% | 5.450.229 |
| 27/08/1992 | 24,39 | 24,45 | 23,74 | 23,80 | -1,97% | 2,93% | 2.477.262 |
| 26/08/1992 | 24,39 | 24,57 | 24,21 | 24,27 | -0,25% | 1,47% | 1.830.856 |